
Jeffrey E. Russel
Examiner (ID: 13185, Phone: (571)272-0969 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1815, 1103, 1621, 1811, 1653, 1675, 2899, 1654, 1809 |
| Total Applications | 3437 |
| Issued Applications | 2371 |
| Pending Applications | 237 |
| Abandoned Applications | 837 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10620551
[patent_doc_number] => 09339476
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-17
[patent_title] => 'Implantable meshes for controlling the movement of fluids'
[patent_app_type] => utility
[patent_app_number] => 14/466699
[patent_app_country] => US
[patent_app_date] => 2014-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19633
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14466699
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/466699 | Implantable meshes for controlling the movement of fluids | Aug 21, 2014 | Issued |
Array
(
[id] => 11582918
[patent_doc_number] => 09637542
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-02
[patent_title] => 'CX3CR1-targeting imaging agents and their use in the diagnosis and treatment of disease'
[patent_app_type] => utility
[patent_app_number] => 14/463689
[patent_app_country] => US
[patent_app_date] => 2014-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18616
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 451
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14463689
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/463689 | CX3CR1-targeting imaging agents and their use in the diagnosis and treatment of disease | Aug 19, 2014 | Issued |
Array
(
[id] => 9805201
[patent_doc_number] => 20150017146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-15
[patent_title] => 'METHOD OF ENHANCING EFFICACY OF BLOOD TRANSFUSIONS'
[patent_app_type] => utility
[patent_app_number] => 14/454059
[patent_app_country] => US
[patent_app_date] => 2014-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12886
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14454059
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/454059 | Method of enhancing efficacy of blood transfusions | Aug 6, 2014 | Issued |
Array
(
[id] => 10978318
[patent_doc_number] => 20160175261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'METHODS AND COMPOSITIONS FOR MODIFYING MUCOUS MEMBRANES'
[patent_app_type] => utility
[patent_app_number] => 14/908927
[patent_app_country] => US
[patent_app_date] => 2014-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 20014
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14908927
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/908927 | Methods and compositions for modifying mucous membranes | Jul 27, 2014 | Issued |
Array
(
[id] => 12036539
[patent_doc_number] => 09814753
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-14
[patent_title] => 'Methods and compositions comprising desmopressin in combination with a beta-3-adrenergic receptor agonist'
[patent_app_type] => utility
[patent_app_number] => 14/338554
[patent_app_country] => US
[patent_app_date] => 2014-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12758
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14338554
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/338554 | Methods and compositions comprising desmopressin in combination with a beta-3-adrenergic receptor agonist | Jul 22, 2014 | Issued |
Array
(
[id] => 12253101
[patent_doc_number] => 09925232
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-27
[patent_title] => 'Methods and compositions comprising desmopressin in combination with a 5-alpha reductase inhibitor'
[patent_app_type] => utility
[patent_app_number] => 14/338567
[patent_app_country] => US
[patent_app_date] => 2014-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16214
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14338567
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/338567 | Methods and compositions comprising desmopressin in combination with a 5-alpha reductase inhibitor | Jul 22, 2014 | Issued |
Array
(
[id] => 10813701
[patent_doc_number] => 20160159861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'APJ Receptor Compounds'
[patent_app_type] => utility
[patent_app_number] => 14/905629
[patent_app_country] => US
[patent_app_date] => 2014-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 32119
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14905629
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/905629 | APJ Receptor Compounds | Jul 17, 2014 | Abandoned |
Array
(
[id] => 10926729
[patent_doc_number] => 20140329750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-06
[patent_title] => 'Growth Hormones with Prolonged In-Vivo Efficacy'
[patent_app_type] => utility
[patent_app_number] => 14/334095
[patent_app_country] => US
[patent_app_date] => 2014-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27818
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14334095
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/334095 | Growth Hormones with Prolonged In-Vivo Efficacy | Jul 16, 2014 | Abandoned |
Array
(
[id] => 10265941
[patent_doc_number] => 20150150938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-04
[patent_title] => 'PHARMACEUTICAL FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/326939
[patent_app_country] => US
[patent_app_date] => 2014-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9429
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14326939
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/326939 | Methods using desmopressin acetate in orodispersible form | Jul 8, 2014 | Issued |
Array
(
[id] => 10978438
[patent_doc_number] => 20160175381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'INTRAARTICULAR APPLICATION OF PEPSTATIN IN THE CASE OF ARTHROSIS'
[patent_app_type] => utility
[patent_app_number] => 14/910317
[patent_app_country] => US
[patent_app_date] => 2014-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12284
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14910317
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/910317 | Intraarticular application of pepstatin in the case of arthrosis | Jul 6, 2014 | Issued |
Array
(
[id] => 10056205
[patent_doc_number] => 09095545
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-04
[patent_title] => 'Methods for treating gastrointestinal disorders associated with Parkinson\'s disease, autism, diabetic gastroparesis'
[patent_app_type] => utility
[patent_app_number] => 14/324924
[patent_app_country] => US
[patent_app_date] => 2014-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4409
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14324924
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/324924 | Methods for treating gastrointestinal disorders associated with Parkinson's disease, autism, diabetic gastroparesis | Jul 6, 2014 | Issued |
Array
(
[id] => 9799518
[patent_doc_number] => 20150011462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-08
[patent_title] => 'DERIVATIVES OF GLP-1 LIKE PEPTIDES, AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/322077
[patent_app_country] => US
[patent_app_date] => 2014-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43772
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14322077
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/322077 | Derivatives of GLP-1 like peptides, and uses thereof | Jul 1, 2014 | Issued |
Array
(
[id] => 11930921
[patent_doc_number] => 09797912
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-24
[patent_title] => 'Diagnostic method for inflammatory bowel disease'
[patent_app_type] => utility
[patent_app_number] => 14/900867
[patent_app_country] => US
[patent_app_date] => 2014-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 17060
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14900867
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/900867 | Diagnostic method for inflammatory bowel disease | Jun 26, 2014 | Issued |
Array
(
[id] => 10980089
[patent_doc_number] => 20160177032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'PRODUCTION METHOD FOR POLY(AMINO ACID)'
[patent_app_type] => utility
[patent_app_number] => 14/392185
[patent_app_country] => US
[patent_app_date] => 2014-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 49656
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14392185
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/392185 | Production method for poly(amino acid) | Jun 24, 2014 | Issued |
Array
(
[id] => 11003814
[patent_doc_number] => 20160200763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'GLYCOGEN SYNTHASE KINASE-3 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/392205
[patent_app_country] => US
[patent_app_date] => 2014-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 30356
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14392205
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/392205 | Glycogen synthase kinase-3 inhibitors | Jun 23, 2014 | Issued |
Array
(
[id] => 10813697
[patent_doc_number] => 20160159858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'URIC ACID-LOWERING AGENT'
[patent_app_type] => utility
[patent_app_number] => 14/787677
[patent_app_country] => US
[patent_app_date] => 2014-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6398
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14787677
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/787677 | Uric acid-lowering agent | Jun 19, 2014 | Issued |
Array
(
[id] => 10799149
[patent_doc_number] => 20160145307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'ULTRA-PURE AGONISTS OF GUANYLATE CYCLASE C, METHOD OF MAKING AND USING SAME'
[patent_app_type] => utility
[patent_app_number] => 14/896019
[patent_app_country] => US
[patent_app_date] => 2014-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 47310
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14896019
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/896019 | Ultra-pure agonists of guanylate cyclase C, method of making and using same | Jun 4, 2014 | Issued |
Array
(
[id] => 10522712
[patent_doc_number] => 09249210
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-02-02
[patent_title] => 'Recombinant expression vector system for variants of coagulation factor VIII and von Willebrand factor'
[patent_app_type] => utility
[patent_app_number] => 14/291713
[patent_app_country] => US
[patent_app_date] => 2014-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 8193
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14291713
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/291713 | Recombinant expression vector system for variants of coagulation factor VIII and von Willebrand factor | May 29, 2014 | Issued |
Array
(
[id] => 9735819
[patent_doc_number] => 20140271532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'COMBINATION THERAPY WITH GLATIRAMER ACETATE AND RASAGILINE FOR THE TREATMENT OF MULTIPLE SCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 14/292511
[patent_app_country] => US
[patent_app_date] => 2014-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5145
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14292511
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/292511 | COMBINATION THERAPY WITH GLATIRAMER ACETATE AND RASAGILINE FOR THE TREATMENT OF MULTIPLE SCLEROSIS | May 29, 2014 | Abandoned |
Array
(
[id] => 10939972
[patent_doc_number] => 20140342993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-20
[patent_title] => 'KINASE INHIBITORS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/258418
[patent_app_country] => US
[patent_app_date] => 2014-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 32662
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14258418
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/258418 | Kinase inhibitors and uses thereof | Apr 21, 2014 | Issued |